US Industry Earnings Intelligence

Medical Devices earnings map

Forward reporting exposure, estimate delivery, earnings growth and company-level event concentration.

Forward window14 Aug to 12 Nov 202614 matched companies

Group read

Delivery breadth and earnings growth are under pressure

42% of companies with measured latest results beat estimates, while 33% show positive year-on-year EPS growth. Healthcare carries the largest forward market-cap exposure.

Forward events15next 90 days
Market-cap exposure$298.8Bmatched companies
Latest beat breadth42%latest measured quarter
Positive EPS growth33%year on year

Forward exposure

Medical Devices reporting load by date

Count and matched market cap

Delivery

Latest result breadth

42%beat breadth

Timing

Session certainty

47%estimate coverage

Growth breadth

Positive versus contracting

Company size

Capital at risk by tier

Company attention queue

Most consequential upcoming reports

Ordered by market capitalisation so the largest potential peer and index read-through appears first.

14 shown
ABTAbbott LaboratoriesMedical Devices
14 Oct61 days
Event risk14/100Contained
Market cap$149.2BTime unconfirmed
Beat rate50%up to 8 quarters
EPS growth-61.2%year on year
Open earnings dossier
MDTMedtronic PLCMedical Devices
1 Sep18 days
Event risk15/100Contained
Market cap$97.5BBefore the open
Beat rate100%up to 8 quarters
EPS growth2.9%year on year
Open earnings dossier
EWEdwards Lifesciences CorpMedical Devices
29 Oct76 days
Event risk20/100Contained
Market cap$49.8BTime unconfirmed
Beat rate88%up to 8 quarters
EPS growth-75.8%year on year
Open earnings dossier
NVCRNovocure LtdMedical Devices
29 Oct76 days
Event risk38/100Moderate
Market cap$2.0BTime unconfirmed
Beat rate75%up to 8 quarters
EPS growth-year on year
Open earnings dossier
SNWVSANUWAVE Health, Inc. Common StockMedical Devices
14 Aug0 days
Event risk65/100Elevated
Market cap$140.2MTime unconfirmed
Beat rate40%up to 8 quarters
EPS growth-year on year
Open earnings dossier
PAVMPAVmed IncMedical Devices
14 Aug0 days
Event risk55/100Elevated
Market cap$45.1MBefore the open
Beat rate88%up to 8 quarters
EPS growth-year on year
Open earnings dossier
ARAYAccuray IncorporatedMedical Devices
19 Aug5 days
Event risk56/100Elevated
Market cap$45.0MAfter the close
Beat rate38%up to 8 quarters
EPS growth-year on year
Open earnings dossier
IRIXIRIDEX CorporationMedical Devices
18 Aug4 days
Event risk56/100Elevated
Market cap$18.3MAfter the close
Beat rate50%up to 8 quarters
EPS growth-year on year
Open earnings dossier
AIDX20/20 Biolabs, Inc. Common StockMedical Devices
19 Aug5 days
Event risk36/100Moderate
Market cap$10.1MTime unconfirmed
Beat rate0%up to 8 quarters
EPS growth-year on year
Open earnings dossier
VVOSVivos Therapeutics IncMedical Devices
18 Aug4 days
Event risk56/100Elevated
Market cap$9.3MTime unconfirmed
Beat rate50%up to 8 quarters
EPS growth-year on year
Open earnings dossier
BMRABiomerica IncMedical Devices
4 Sep21 days
Event risk24/100Contained
Market cap$7.6MTime unconfirmed
Beat rate-up to 8 quarters
EPS growth-year on year
Open earnings dossier
INBSIntelligent Bio Solutions Inc.Medical Devices
21 Aug7 days
Event risk61/100Elevated
Market cap$6.1MTime unconfirmed
Beat rate0%up to 8 quarters
EPS growth-year on year
Open earnings dossier
FEEDENvue Medical Inc.Medical Devices
18 Aug4 days
Event risk36/100Moderate
Market cap$5.6MTime unconfirmed
Beat rate-up to 8 quarters
EPS growth-year on year
Open earnings dossier
HSCSHeart Test Laboratories Inc. Common StockMedical Devices
10 Sep27 days
Event risk42/100Moderate
Market cap$5.3MTime unconfirmed
Beat rate63%up to 8 quarters
EPS growth-year on year
Open earnings dossier

Forward company tape

Medical Devices upcoming earnings reports

15 shown

Interpretation

How to read group earnings intelligence

Calendar concentration

Counts show operational density. Market-cap exposure identifies dates with greater potential for peer and index read-through.

Delivery breadth

Only the latest measured result per matched company enters the breadth split, preventing long-history companies from dominating.

Growth breadth

Positive year-on-year EPS growth is kept separate from estimate surprise because growth and expectations answer different questions.

Decision use

The page helps prioritise research and event risk. It does not determine whether to buy, sell or expect a directional reaction.

Evidence context